Pharmacogenomic Testing: Delivering Precision Medicine

By reducing adverse drug responses, improving efficacy, and ensuring each patient gets the drug they are most likely to respond to, pharmacogenomics testing helps deliver the promise of precision medicine. In order to help empower the personalization of cancer treatment, we offer pharmacogenomic testing for doctors, hospitals, and cancer centers, as well as for biopharma and biotech companies engaged in oncology-focused clinical trials.

Below is a sample of the pharmacogenomic genotyping assays we offer for drug metabolism. In addition to conventional pharmacogenomics tests, we are experienced in providing custom assay development and validation.

ABCB1
ABCB11
ABCC2
AOX1
CDA
CYP17A1
CYP2A6
CYP2B6
CYP2C10
CYP2C8
CYP2C9
CYP2D6
CYP3A4
CYP3A5
GST
NAT1
NAT2
NR1l2
NR1l3
PM202D2
SLC6A13
SLC6A6
SLCO1B1
TMEM186
UGT1A1
UGT1A4
UGT2B7